Literature DB >> 6818244

Broth microdilution testing of Pseudomonas aeruginosa and aminoglycosides: need for employing dilutions differing by small arithmetic increments.

B F Woolfrey, J M Fox, R T Lally, C O Quall.   

Abstract

The use of dilutions differing by small arithmetic increments was studied as a means for improving the definition and measurement of minimum inhibitory concentrations and precision parameters for testing Pseudomonas aeruginosa versus the aminoglycosides by the broth microdilution test. For five strains of P. aeruginosa versus gentamicin, tobramycin, and amikacin, comparisons were made of minimum inhibitory concentrations which were replicated in parallel by using three microdilution systems: small increment panels prepared by us, modified twofold dilution panels prepared by us, and similar modified twofold dilution panels obtained commercially. The small increment dilutions were prepared to differ by concentrations of 1.0 microgram/ml for gentamicin and tobramycin and by 2.0 micrograms/ml for amikacin. Use of the small increment dilutions resulted in the ability to measure minimum inhibitory concentrations at more closely spaced intervals than those dictated by modified twofold dilution schemes, and confidence limits were significantly improved. The average coefficient of variation for the small increment microdilution test results was 9.5%, with 99.5% of minimum inhibitory concentrations falling within +/- 2 small increment dilutions from their modal values.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818244      PMCID: PMC272442          DOI: 10.1128/jcm.16.4.663-667.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Evaluation of the moving intermediate zone concept for determing susceptibility of pseudomonads to gentamicin by the standardized disk agar-diffusion test.

Authors:  B F Woolfrey; W A Ramadei; C O Quall
Journal:  Am J Clin Pathol       Date:  1979-11       Impact factor: 2.493

2.  Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media.

Authors:  L B Reller; F D Schoenknecht; M A Kenny; J C Sherris
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

3.  Interpretation of agar diffusion tests.

Authors:  C Krasemann; G Hildenbrand
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

4.  Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa.

Authors:  H M Pollock; B H Minshew; M A Kenny; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

5.  Inability of the standardized disk agar-diffusion test to measure susceptibility of the fluorescent group of pseudomonads to gentamicin.

Authors:  B F Woolfrey; W A Ramadei; C O Quall
Journal:  Am J Clin Pathol       Date:  1978-09       Impact factor: 2.493

6.  Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin.

Authors:  M A Kenny; H M Pollock; B H Minshew; E Casillas; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

7.  Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal function.

Authors:  D E Zaske; R J Cipolle; R J Strate
Journal:  Surgery       Date:  1980-02       Impact factor: 3.982

8.  Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation.

Authors:  A L Barry; C Thornsberry; R N Jones; E H Gerlach
Journal:  Am J Clin Pathol       Date:  1981-04       Impact factor: 2.493

9.  Amikacin serum concentrations: prediction of levels and dosage guidelines.

Authors:  F A Sarubbi; J H Hull
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

10.  Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa.

Authors:  B F Woolfrey; J M Fox; C O Quall
Journal:  Am J Clin Pathol       Date:  1981-01       Impact factor: 2.493

View more
  9 in total

Review 1.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

2.  Antibiotic interaction: interpretation of fractional inhibitory and fractional bactericidal concentration indices.

Authors:  A M Horrevorts; M F Michel; K F Kerrebijn
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

3.  Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin.

Authors:  B F Woolfrey; R T Lally; C O Quall
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

4.  Pseudomonas aeruginosa ATCC 49189, a new quality control strain for testing P. aeruginosa susceptibility to the aminoglycosides.

Authors:  R T Lally; B F Woolfrey; M A Enright
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

5.  Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin.

Authors:  B F Woolfrey; R T Lally; M N Ederer; C O Quall
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

6.  Evaluation of the automicrobic system for detection of resistance of Staphylococcus aureus to methicillin.

Authors:  B F Woolfrey; R T Lally; M N Ederer
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

7.  Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.

Authors:  B F Woolfrey; J M Fox; C O Quall; R T Lally
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

8.  Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.

Authors:  R B Clark; C C Sanders; C B Pakiz; M K Hostetter
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

9.  Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms.

Authors:  T A Larson; L R Peterson; D N Gerding
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.